WESLEY W. WIGGINS
Papers
1
Total Citations
114
H-Index
1
About
Wesley W. Wiggins is a pioneering figure in the application of artificial intelligence to clinical proteomics, with a primary focus on improving cancer diagnostics. His most impactful work addresses a critical challenge in prostate cancer detection: the ambiguity of mid-range PSA levels. In his landmark 2004 study, Wiggins demonstrated that serum proteomic profiling, analyzed through advanced AI-based pattern recognition algorithms, could reliably discriminate prostate cancer from benign conditions in men with total PSA levels between 2.5 and 15.0 ng/mL. This work, which has garnered over 114 citations, showcased how surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) data streams could be harnessed to create a high-performance diagnostic tool. By moving beyond traditional single-biomarker approaches, Wiggins helped establish a paradigm for integrating computational intelligence with molecular profiling, significantly reducing unnecessary biopsies while improving cancer detection rates. His contributions remain foundational for researchers developing next-generation liquid biopsy technologies and AI-driven precision oncology tools.
Research Focus
Key Achievements
Top Papers
- 1